ARTICLE | Company News
AstraZeneca returns rights to Shire
July 23, 2001 7:00 AM UTC
Shire (LSE:SHP; SHPGY) said AstraZeneca (AZN; LSE:AZN) returned rights to its frakefamide opioid analgesic based on negative results from its Phase II anterior cruciate ligament repair study. The comp...